All In Biotech

Drug Trial Radar · NCT05026866

A Donanemab (LY3002813) Study in Participants With Preclinical Alzheimer's Disease (TRAILBLAZER-ALZ 3)

A Study of Donanemab Versus Placebo in Participants at Risk for Cognitive and Functional Decline of Alzheimer's Disease

Last checked: Nov 20, 2026Latest source record: Jan 21, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Active, not recruitingPivotal-lookingPhase 3. Randomized with 2,996 participants. This is a heuristic, not a regulatory label.

Status

Active, not recruiting

Enrollment

2,996

Planned (sponsor's estimate)

Start

Aug 27, 2021

Primary completion

Nov 2027

Study completion Nov 2027

Sponsor

Lead sponsor
Eli Lilly and CompanyEli Lilly (LLY)
Sponsor type
Industry
First posted
Aug 30, 2021

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Double (participant, investigator)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 55 years, up to 80 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The main purpose of this study is to evaluate the safety and efficacy of donanemab in participants with preclinical Alzheimer's Disease (AD) over up to 332 weeks. Approximately 800 additional participants will be enrolled in the 12-month Addendum 7 to assess safety of a different titration regimen.

Conditions

  • Alzheimer Disease

Interventions

  • DonanemabDrug

    Administered intravenously

  • PlaceboDrug

    Administered intravenously

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Time to Clinical Progression of Composite Endpoint as Measured by Clinical Dementia Rating (CDR) in the Primary Study Population (Baseline CDR-Global Score [GS 0])Time frame: Estimated up to Week 332

Locations

216 sites in 3 countries. Site status is shown where the registry gives one.

  • Parkway Medical Center

    Birmingham, Alabama

  • Alabama Psychiatry - Birmingham - Brookwood Medical Center Drive

    Homewood, Alabama

  • Rehabilitation & Neurological Services

    Huntsville, Alabama

  • Care Access - 801 South Power Road, Mesa

    Mesa, Arizona

  • Banner Alzheimer's Institute

    Phoenix, Arizona

  • Banner Alzheimer's Institute Tucson

    Tucson, Arizona

  • Center for Neurosciences

    Tucson, Arizona

  • Care Access - Berkeley

    Berkeley, California

  • Care Access - Beverly Hills

    Beverly Hills, California

  • Velocity Clinical Research, Chula Vista

    Chula Vista, California

  • Valley Clinical Trials, Inc.

    Covina, California

  • Neurology Center of North Orange County

    Fullerton, California

  • Care Access - Gilroy

    Gilroy, California

  • Marvel Clinical Research

    Huntington Beach, California

  • Care Access Research - Huntington Beach

    Huntington Beach, California

  • Irvine Clinical Research

    Irvine, California

  • Option Care - Irvine

    Irvine, California

  • Kaizen Brain Center

    La Jolla, California

  • Velocity Clinical Research, San Diego

    La Mesa, California

  • Pacific Research Network

    Lemon Grove, California

  • Healthy Brain Clinic

    Long Beach, California

  • Neurovations

    Napa, California

  • Care Access - Newport Beach

    Newport Beach, California

  • Valley Clinical Trials, Inc.

    Northridge, California

  • Inland Psychiatric Medical Group

    Redlands, California

  • Anderson Clinical Research

    Redlands, California

  • Artemis Institute for Clinical Research

    Riverside, California

  • Option Care - Riverside

    Riverside, California

  • Clinical Trials Research

    Sacramento, California

  • Artemis Institute for Clinical Research

    San Diego, California

  • Ray Dolby Brain Health Center

    San Francisco, California

  • Care Access - Los Gatos

    San Jose, California

  • Syrentis Clinical Research

    Santa Ana, California

  • Care Access - Santa Clarita

    Santa Clarita, California

  • Option Care - Los Angeles South

    Santa Fe Springs, California

  • Providence Medical Foundation

    Santa Rosa, California

  • Mazur, Statner, Dutta, Nathan, PC

    Thousand Oaks, California

  • Tilda Research

    Tustin, California

  • Velocity Clinical Research, Panorama City

    Van Nuys, California

  • Infectious Disease Doctors Medical Group, APC

    Walnut Creek, California

Showing 40 of 216 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.